Sudapack breaks ground on major PharmaGuard expansion in Erolzheim
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor
Clinical trials found that 77% of patients went into remission after receiving obe-cel
Subscribe To Our Newsletter & Stay Updated